Healthcare

Veterinary Dietary Supplements Market Size To Rake US$ 8.3 billion by 2030

Share This Article

The global Veterinary Dietary Supplements market size is expected to be worth around US$ 8.3 billion by 2030, according to a new report by Vision Research Reports.

Veterinary Dietary Supplements Market (By Animal Type: Livestock Animals, Companion Animals; By Application: Joint Health Support, Calming/ Stress/ Anxiety, Digestive Health, Energy and Electrolytes, Immunity Support, Skin & Coat Health; By Type: Omega 3 Fatty Acids, Proteins & Peptides, CBD, Multivitamins & Minerals, Probiotics & Prebiotics, Others; By Dosage Form: Tablets & Capsules, Gummies & Chewables, Powders, Liquids, Others; By Distribution Channel: Online/ E-commerce, Offline) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/38314

Report Highlights

The companion animals segment dominated the market and held the largest revenue share of over 65.0% in 2020. This can be attributed to growing initiatives by market players, pet population, and humanization. The segment is also expected to witness the highest CAGR of 10.3% from 2021 to 2030. Ark Naturals Company, based in the U.S. specializes in nutraceuticals for companion animals and uses human-grade raw materials to formulate its veterinary dietary supplements.

The livestock animals segment is also expected to grow significantly over the forecast period. Supplements are added to livestock feed to improve the performance or nutrient balance of the total ratio. It can be administered free choice with other parts of the ration if available separately, diluted with other feeds, or further diluted and mixed to produce a complete feed. The need to increase profitability while protecting the health of livestock assets is anticipated to drive the segment.

The joint health support segment dominated the market and accounted for the largest revenue share of 25.0% in 2020. The key factors contributing to the large share include the increasing prevalence of chronic joint disorders in companion as well as livestock animals and awareness about the availability of a variety of joint health supplements that help prevent or slow joint health disorders. As per a June 2020 study published in the Journal of the American Veterinary Medical Association, the use of joint health supplements may help to prevent or slow the progression of osteoarthritis in cats and dogs. Omega-3 Fatty Acids, green-lipped mussel, and glucosamine and chondroitin sulfate are commonly used dietary components associated with improvement in clinical signs of osteoarthritis in companion animals.

The multivitamins and minerals segment dominated the market and accounted for the largest revenue share of 30.5% in 2020. This can be attributed to the rising use of these veterinary dietary supplements in both companions as well as livestock animals to ensure balanced diets and promote daily bodily functions. A review article was published in Advances in Animal and Veterinary Sciences in 2019 on the Effect of multivitamin and amino acid supplements on Average Daily Gain (AVD) in crossbred Holstein calves. The results indicated a significant increase in ADG thus presenting an alternative growth rate management method in calves with poor growth performance.

The gummies and chewables segment dominated the market and accounted for the largest revenue share of 55.3% in 2020. The powders segment is expected to witness the fastest CAGR of 10.6% over the forecast period. This is owing to growing initiatives by market players in the pet food, treats, and supplements market to investigate and improve palatability in animals. Palatability studies are primarily based on the acceptance that is the choice to consume or not consume a particular dosage form and preference between dosage forms.

The offline channel segment dominated the market and accounted for the largest revenue share of 68.9% in 2020. This is owing to a large number of pet owners and livestock farm operators opting for brick-and-mortar purchasing as the channel of choice. However, e-commerce and other online channels had been gaining traction for the past few years. Many offline stores even began offering customers a choice between ordering online and purchasing offline to increase sales.

The COVID-19 pandemic has catalyzed the adoption of online/ e-commerce channels and the segment is expected to register a high CAGR of 19.2% over the forecast period. This is expected to lead to further fragmentation of an already intensely competitive market. In March 2021, for example, Happy Go Healthy launched its line of premium dog supplements- Brilliant Bites onAmazon.com and Walmart.com.

North America dominated the veterinary dietary supplements market and accounted for the largest revenue share of over 39.0% in 2020. The key factors responsible for the large share of the market in the region include the presence of key players and the increasing trend of pet humanization and premiumization of pet products. In October 2018, Nutramax, a leading company that develops products for humans and companion animals including dietary supplements, expanded operations at its Lancaster facility with a USD 20.0 million investment.

Key Players

  • Boehringer Ingelheim
  • Virbac
  • Ark Naturals Company
  • Beaphar
  • FoodScience
  • NOW Foods
  • Nutramax Laboratories, Inc.
  • Nutri-Pet Research, Inc.
  • Ceva
  • Canna Companion
  • Nestle

Market Segmentation

  • Animal Type Outlook
    • Livestock Animals
    • Companion Animals
      • Cats
      • Dogs
      • Horses
      • Others (Small Animals, Birds)
  • Application Outlook
    • Joint Health Support
    • Calming/ Stress/ Anxiety
    • Digestive Health
    • Energy and Electrolytes
    • Immunity Support
    • Skin & Coat Health
    • Others (Kidney, Urinary Tract, Liver, Cardiovascular, Weight Management)
  • Type Outlook
    • Omega 3 Fatty Acids
    • Proteins & Peptides
    • CBD
    • Multivitamins & Minerals
    • Probiotics & Prebiotics
    • Others (Antioxidants)
  • Dosage Form Outlook
    • Tablets & Capsules
    • Gummies & Chewables
    • Powders
    • Liquids
    • Others (Injectables, Paste)
  • Distribution Channel Outlook
    • Online/ E-commerce
    • Offline
      • Pet Specialty Stores
      • Retail
      • Others
  • Regional Outlook
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
    • Spain
      • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
    • Latin America
      • Brazil
      • Mexico
      • Argentina
    • MEA
      • South Africa
      • Saudi Arabia

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38314

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Veterinary Dietary Supplements Market, By Animal Type

7.1.  Veterinary Dietary Supplements Market, by Animal Type, 2020-2030

7.1.1.    Livestock Animals

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Companion Animals

7.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Veterinary Dietary Supplements Market, By Application

8.1.  Veterinary Dietary Supplements Market, by Application, 2020-2030

8.1.1.    Joint Health Support

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Calming/ Stress/ Anxiety

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Digestive Health

8.1.3.1.        Market Revenue and Forecast (2016-2030)

8.1.4.    Energy and Electrolytes

8.1.4.1.        Market Revenue and Forecast (2016-2030)

8.1.5.    Immunity Support

8.1.5.1.        Market Revenue and Forecast (2016-2030)

8.1.6.    Skin & Coat Health

8.1.6.1.        Market Revenue and Forecast (2016-2030)

8.1.7.    Others (Kidney, Urinary Tract, Liver, Cardiovascular, Weight Management)

8.1.7.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Veterinary Dietary Supplements Market, By Type

9.1.  Veterinary Dietary Supplements Market, by Type, 2020-2030

9.1.1.    Omega 3 Fatty Acids

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Proteins & Peptides

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    CBD

9.1.3.1.        Market Revenue and Forecast (2016-2030)

9.1.4.    Multivitamins & Minerals

9.1.4.1.        Market Revenue and Forecast (2016-2030)

9.1.5.    Probiotics & Prebiotics

9.1.5.1.        Market Revenue and Forecast (2016-2030)

9.1.6.    Others (Antioxidants)

9.1.6.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Veterinary Dietary Supplements Market, By Dosage Form

10.1.        Veterinary Dietary Supplements Market, by Dosage Form, 2020-2030

10.1.1.  Tablets & Capsules

10.1.1.1.      Market Revenue and Forecast (2016-2030)

10.1.2.  Gummies & Chewables

10.1.2.1.      Market Revenue and Forecast (2016-2030)

10.1.3.  Powders

10.1.3.1.      Market Revenue and Forecast (2016-2030)

10.1.4.  Liquids

10.1.4.1.      Market Revenue and Forecast (2016-2030)

10.1.5.  Others (Injectables, Paste)

10.1.5.1.      Market Revenue and Forecast (2016-2030)

Chapter 11.      Global Veterinary Dietary Supplements Market, By Distribution Channel

11.1.        Veterinary Dietary Supplements Market, by Distribution Channel, 2020-2030

11.1.1.  Online/ E-commerce

11.1.1.1.      Market Revenue and Forecast (2016-2030)

11.1.2.  Offline

11.1.2.1.      Market Revenue and Forecast (2016-2030)

Chapter 12.      Global Veterinary Dietary Supplements  Market, Regional Estimates and Trend Forecast

12.1.        North America

12.1.1.  Market Revenue and Forecast, by Animal Type (2016-2030)

12.1.2.  Market Revenue and Forecast, by Application (2016-2030)

12.1.3.  Market Revenue and Forecast, by Type (2016-2030)

12.1.4.  Market Revenue and Forecast, by Dosage Form (2016-2030)

12.1.5.  Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.1.6.  U.S.

12.1.6.1.      Market Revenue and Forecast, by Animal Type (2016-2030)

12.1.6.2.      Market Revenue and Forecast, by Application (2016-2030)

12.1.6.3.      Market Revenue and Forecast, by Type (2016-2030)

12.1.6.4.      Market Revenue and Forecast, by Dosage Form (2016-2030)

12.1.6.5.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.1.7.  Rest of North America

12.1.7.1.      Market Revenue and Forecast, by Animal Type (2016-2030)

12.1.7.2.      Market Revenue and Forecast, by Application (2016-2030)

12.1.7.3.      Market Revenue and Forecast, by Type (2016-2030)

12.1.7.4.      Market Revenue and Forecast, by Dosage Form (2016-2030)

12.1.7.5.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.2.        Europe

12.2.1.  Market Revenue and Forecast, by Animal Type (2016-2030)

12.2.2.  Market Revenue and Forecast, by Application (2016-2030)

12.2.3.  Market Revenue and Forecast, by Type (2016-2030)

12.2.4.  Market Revenue and Forecast, by Dosage Form (2016-2030)

12.2.5.  Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.2.6.  UK

12.2.6.1.      Market Revenue and Forecast, by Animal Type (2016-2030)

12.2.6.2.      Market Revenue and Forecast, by Application (2016-2030)

12.2.6.3.      Market Revenue and Forecast, by Type (2016-2030)

12.2.6.4.      Market Revenue and Forecast, by Dosage Form (2016-2030)

12.2.6.5.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.2.7.  Germany

12.2.7.1.      Market Revenue and Forecast, by Animal Type (2016-2030)

12.2.7.2.      Market Revenue and Forecast, by Application (2016-2030)

12.2.7.3.      Market Revenue and Forecast, by Type (2016-2030)

12.2.7.4.      Market Revenue and Forecast, by Dosage Form (2016-2030)

12.2.7.5.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.2.8.  France

12.2.8.1.      Market Revenue and Forecast, by Animal Type (2016-2030)

12.2.8.2.      Market Revenue and Forecast, by Application (2016-2030)

12.2.8.3.      Market Revenue and Forecast, by Type (2016-2030)

12.2.8.4.      Market Revenue and Forecast, by Dosage Form (2016-2030)

12.2.8.5.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.2.9.  Rest of Europe

12.2.9.1.      Market Revenue and Forecast, by Animal Type (2016-2030)

12.2.9.2.      Market Revenue and Forecast, by Application (2016-2030)

12.2.9.3.      Market Revenue and Forecast, by Type (2016-2030)

12.2.9.4.      Market Revenue and Forecast, by Dosage Form (2016-2030)

12.2.9.5.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.3.        APAC

12.3.1.  Market Revenue and Forecast, by Animal Type (2016-2030)

12.3.2.  Market Revenue and Forecast, by Application (2016-2030)

12.3.3.  Market Revenue and Forecast, by Type (2016-2030)

12.3.4.  Market Revenue and Forecast, by Dosage Form (2016-2030)

12.3.5.  Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.3.6.  India

12.3.6.1.      Market Revenue and Forecast, by Animal Type (2016-2030)

12.3.6.2.      Market Revenue and Forecast, by Application (2016-2030)

12.3.6.3.      Market Revenue and Forecast, by Type (2016-2030)

12.3.6.4.      Market Revenue and Forecast, by Dosage Form (2016-2030)

12.3.6.5.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.3.7.  China

12.3.7.1.      Market Revenue and Forecast, by Animal Type (2016-2030)

12.3.7.2.      Market Revenue and Forecast, by Application (2016-2030)

12.3.7.3.      Market Revenue and Forecast, by Type (2016-2030)

12.3.7.4.      Market Revenue and Forecast, by Dosage Form (2016-2030)

12.3.7.5.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.3.8.  Japan

12.3.8.1.      Market Revenue and Forecast, by Animal Type (2016-2030)

12.3.8.2.      Market Revenue and Forecast, by Application (2016-2030)

12.3.8.3.      Market Revenue and Forecast, by Type (2016-2030)

12.3.8.4.      Market Revenue and Forecast, by Dosage Form (2016-2030)

12.3.8.5.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.3.9.  Rest of APAC

12.3.9.1.      Market Revenue and Forecast, by Animal Type (2016-2030)

12.3.9.2.      Market Revenue and Forecast, by Application (2016-2030)

12.3.9.3.      Market Revenue and Forecast, by Type (2016-2030)

12.3.9.4.      Market Revenue and Forecast, by Dosage Form (2016-2030)

12.3.9.5.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.4.        MEA

12.4.1.  Market Revenue and Forecast, by Animal Type (2016-2030)

12.4.2.  Market Revenue and Forecast, by Application (2016-2030)

12.4.3.  Market Revenue and Forecast, by Type (2016-2030)

12.4.4.  Market Revenue and Forecast, by Dosage Form (2016-2030)

12.4.5.  Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.4.6.  GCC

12.4.6.1.      Market Revenue and Forecast, by Animal Type (2016-2030)

12.4.6.2.      Market Revenue and Forecast, by Application (2016-2030)

12.4.6.3.      Market Revenue and Forecast, by Type (2016-2030)

12.4.6.4.      Market Revenue and Forecast, by Dosage Form (2016-2030)

12.4.6.5.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.4.7.  North Africa

12.4.7.1.      Market Revenue and Forecast, by Animal Type (2016-2030)

12.4.7.2.      Market Revenue and Forecast, by Application (2016-2030)

12.4.7.3.      Market Revenue and Forecast, by Type (2016-2030)

12.4.7.4.      Market Revenue and Forecast, by Dosage Form (2016-2030)

12.4.7.5.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.4.8.  South Africa

12.4.8.1.      Market Revenue and Forecast, by Animal Type (2016-2030)

12.4.8.2.      Market Revenue and Forecast, by Application (2016-2030)

12.4.8.3.      Market Revenue and Forecast, by Type (2016-2030)

12.4.8.4.      Market Revenue and Forecast, by Dosage Form (2016-2030)

12.4.8.5.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.4.9.  Rest of MEA

12.4.9.1.      Market Revenue and Forecast, by Animal Type (2016-2030)

12.4.9.2.      Market Revenue and Forecast, by Application (2016-2030)

12.4.9.3.      Market Revenue and Forecast, by Type (2016-2030)

12.4.9.4.      Market Revenue and Forecast, by Dosage Form (2016-2030)

12.4.9.5.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.5.        Latin America

12.5.1.  Market Revenue and Forecast, by Animal Type (2016-2030)

12.5.2.  Market Revenue and Forecast, by Application (2016-2030)

12.5.3.  Market Revenue and Forecast, by Type (2016-2030)

12.5.4.  Market Revenue and Forecast, by Dosage Form (2016-2030)

12.5.5.  Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.5.6.  Brazil

12.5.6.1.      Market Revenue and Forecast, by Animal Type (2016-2030)

12.5.6.2.      Market Revenue and Forecast, by Application (2016-2030)

12.5.6.3.      Market Revenue and Forecast, by Type (2016-2030)

12.5.6.4.      Market Revenue and Forecast, by Dosage Form (2016-2030)

12.5.6.5.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

12.5.7.  Rest of LATAM

12.5.7.1.      Market Revenue and Forecast, by Animal Type (2016-2030)

12.5.7.2.      Market Revenue and Forecast, by Application (2016-2030)

12.5.7.3.      Market Revenue and Forecast, by Type (2016-2030)

12.5.7.4.      Market Revenue and Forecast, by Dosage Form (2016-2030)

12.5.7.5.      Market Revenue and Forecast, by Distribution Channel (2016-2030)

Chapter 13.  Company Profiles

13.1.              Virbac

13.1.1.  Company Overview

13.1.2.  Product Offerings

13.1.3.  Financial Performance

13.1.4.  Recent Initiatives

13.2.              Ark Naturals Company

13.2.1.  Company Overview

13.2.2.  Product Offerings

13.2.3.  Financial Performance

13.2.4.  Recent Initiatives

13.3.              Beaphar

13.3.1.  Company Overview

13.3.2.  Product Offerings

13.3.3.  Financial Performance

13.3.4.  Recent Initiatives

13.4.              FoodScience

13.4.1.  Company Overview

13.4.2.  Product Offerings

13.4.3.  Financial Performance

13.4.4.  Recent Initiatives

13.5.              NOW Foods

13.5.1.  Company Overview

13.5.2.  Product Offerings

13.5.3.  Financial Performance

13.5.4.  Recent Initiatives

13.6.              Nutramax Laboratories, Inc.

13.6.1.  Company Overview

13.6.2.  Product Offerings

13.6.3.  Financial Performance

13.6.4.  Recent Initiatives

13.7.              Nutri-Pet Research, Inc.

13.7.1.  Company Overview

13.7.2.  Product Offerings

13.7.3.  Financial Performance

13.7.4.  Recent Initiatives

13.8.              Ceva

13.8.1.  Company Overview

13.8.2.  Product Offerings

13.8.3.  Financial Performance

13.8.4.  Recent Initiatives

13.9.              Canna Companion

13.9.1.  Company Overview

13.9.2.  Product Offerings

13.9.3.  Financial Performance

13.9.4.  Recent Initiatives

13.10.           Nestle

13.10.1.               Company Overview

13.10.2.               Product Offerings

13.10.3.               Financial Performance

13.10.4.               Recent Initiatives

Chapter 14.  Research Methodology

14.1.              Primary Research

14.2.              Secondary Research

14.3.              Assumptions

Chapter 15.  Appendix

15.1.              About Us

Glossary of Terms

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38314

About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.

Contact Us:

call: +1 9197 992 333

Vision Research Report

Any Assistance, Email – sales@visionresearchreports.com

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Related Articles

Back to top button